Lepu Bio-B (02157) continued to rise in early trading and is now up 14lastpowerballwinningnumbers.88%, reported 4lastpowerballwinningnumbers.40 Hong Kong dollars, with a turnover of 15.72265 million Hong Kong dollars.
The company recently announced that it has a relationship with Conoia-BlastpowerballwinningnumbersKYM, a joint venture company, entered into a licensing agreement with AstraZeneca to develop and commercialize CMG901. Currently, AstraZeneca has conducted multiple clinical studies on CMG901 for the treatment of advanced solid tumors. Among them, an international multicenter Phase III study comparing CMG901 alone with the investigator's chosen regimen as second-line or higher treatment in subjects with advanced or metastatic gastric and gastroesophageal junction adenocarcinoma expressing Claudin 18.2 was announced on the Drug Clinical Trial Registration and Information Platform in March this year, and the first subject completed the first dose on April 11. In addition, the company has also established a cooperative approach to introducing oncolytic virus productslastpowerballwinningnumbersRich and differentiated pipelines.